HBSAG SEROCOVERSION UNDER LAMIVUDINE IN HBEAG-NEGATIVE CHRONIC HEPATITIS B

被引：0
|
作者：
Seven, Gulseren
Idilman, Ramazan
Bozkus, Yusuf
Cinar, Kubilay
Kabacam, Gokhan
Yakut, Mustafa
Bozdayi, A. Mithat [1 ]
Yurdaydin, Cihan [1 ]
机构：
[1] Ankara Univ, Fac Med, Inst Hepatol, TR-06100 Ankara, Turkey
来源：
HEPATOLOGY | 2010年 / 52卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
453
引用
收藏
页码：545A / 546A
页数：2
相关论文
共 50 条
  • [31] Quantitative HBsAg levels do not identify hepatic fibrosis in HBeAg-negative chronic hepatitis B patients
    Ahmed, Fatima A.
    Bajaifar, Maryam S.
    Ahmed, Mohammed A.
    Alalwan, Abduljaleel
    Sanai, Faraaz A.
    Albeladi, Khalid
    Aljumah, Abdulrahman A.
    Sanai, Faisal M.
    SAUDI JOURNAL OF GASTROENTEROLOGY, 2019, 25 (05): : 286 - 292
  • [32] Predictive Value of HBsAg for Off-treatment Response in HBeAg-negative Chronic Hepatitis B Patients
    Fan, Xiaoping
    Li, Tao
    Liu, Feng
    Zhang, Lixin
    Yang, Baohua
    Wang, Lei
    JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN, 2023, 33 (01): : 51 - 56
  • [33] Commentary: HBsAg levels as predictor of sustained response to peg interferon in HBeAg-negative chronic hepatitis B
    Hadziyannis, S. J.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2012, 35 (07) : 842 - 843
  • [34] Lamivudine therapy in HBeAg negative chronic hepatitis B patients
    Guclu, E.
    Batirel, A.
    Ince, N. Koc
    Ogutlu, A.
    Durmaz, Y.
    Ozdemir, D.
    Geyik, M. F.
    Karabay, O.
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2014, 21 : 444 - 444
  • [35] HBeAg-negative chronic hepatitis B: From obscurity to prominence
    Manesis, Emanuel K.
    JOURNAL OF HEPATOLOGY, 2006, 45 (03) : 343 - 346
  • [36] Entecavir versus lamivudine for patients with HBeAg-Negative chronic hepatitis B (vol 354, pg 1011, 2006)
    Lai, CL
    NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (17): : 1863 - 1863
  • [37] LONG-TERM RESPONSE TO LAMIVUDINE MONOTHERAPY IN PATIENTS WITH HBEAG-NEGATIVE CHRONIC HEPATITIS B: TO CHANGE OR NOT TO CHANGE?
    Fasano, Massimo
    Niro, Grazia A.
    Volpe, Anna
    Gaeta, Giovanni B.
    Scotto, Gaetano
    Ippolito, Antonio M.
    Angarano, Gioacchino
    Santantonio, Teresa
    HEPATOLOGY, 2010, 52 (04) : 527A - 527A
  • [38] Severe acute exacerbation of HBeAg-negative chronic hepatitis B has good maintained response to lamivudine treatment
    Chan, H.
    Wong, V.
    Hui, A.
    Tsang, S.
    Chan, J.
    Chan, H.
    Wong, G.
    Sung, J.
    JOURNAL OF CLINICAL VIROLOGY, 2006, 36 : S97 - S98
  • [39] Lamivudine/pegylated interferon alfa-2b sequential combination therapy compared with lamivudine monotherapy in HBeAg-negative chronic hepatitis B
    Vassiliadis, Themistoklis
    Tziomalos, Konstantinos
    Patsiaoura, Kalliopi
    Zagris, Thomas
    Giouleme, Olga
    Soufleris, Konstantinos
    Grammatikos, Nikolaos
    Theodoropoulos, Konstantinos
    Mpoumponaris, Alexandros
    Dona, Konstantina
    Zezos, Petros
    Nikolaidis, Nikolaos
    Orfanou-Koumerkeridou, Eleni
    Balaska, Aikaterini
    Eugenidis, Nikolaos
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2007, 22 (10) : 1582 - 1588
  • [40] Prediction of treatment-related HBsAg loss in HBeAg-negative chronic hepatitis B: a clue from serum HBsAg levels
    Manesis, Emanuel K.
    Hadziyannis, Emilia S.
    Angelopoulou, Olga P.
    Hadziyannis, Stephanos J.
    ANTIVIRAL THERAPY, 2007, 12 (01) : 73 - 82
12345